Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

Annals of Neurology

Volumn 42, Issue 5, 1997, Pages 689-698

  McArthur, Justin C ^a,b,e   McClernon, Daniel R ^c   Cronin, Michael F ^d   Nance Sproson, Tish E ^a   Saah, Alfred J ^b   St Clair, Marty ^c   Lanier, E Randall ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d Organon Teknika Corporation   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; VIRUS RNA;

ARTICLE; BRAIN INFECTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLEOCYTOSIS; PRIORITY JOURNAL;

AIDS DEMENTIA COMPLEX; BIOLOGICAL MARKERS; BRAIN; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HIV-1; HUMANS; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; VIRAL LOAD;

EID: 0030727486     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420504     Document Type: Article

References (68)

1. Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:778-785
2. McArthur JC. Neurologic manifestations of AIDS. Medicine (Baltimore) 1987;66:407-437
3. McArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study. Ann Neurol 1989;26:601-611
4. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993;43: 2245-2252
5. Ho DD, Mougdil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-1625
6. Venet A, Lu W, Beldjord K, Andrieu JM. Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals. AIDS 1991;5:283-288
7. Paul DA, Falk LA, Kessler HA, et al. Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol 1987;22:357-363
8. Goudsmit J, de Wolf F, Paul DA, et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 1986;2:177-180
9. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989; 321:1626-1631
10. Schooley RT. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 1995;9(suppl 2):S15-S19
11. Hogervorst E, Jurriaans S, Dewolf F, et al. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection. Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995;171:811-821
12. Spector SA, Hsia K, Pratt D, et al. Virologie markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J Infect Dis 1993;168:68-74
13. Ho DD, Pomerantz RJ, Kaplan JC. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 1987;317: 278-286
14. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992;30:1768-1771
15. Conrad AJ, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1995; 10:425-435
16. Sei S, Stewart SK, Parley M, et al. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephaloparhy. J Infect Dis 1996;174:1200-1206
17. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175:963-966
18. McCutchan JA, Ellis R, Hsia K, et al. Relationship of cerebrospinal fluid HIV-1 RNA levels (CSF RNA) to plasma RNA pleocytosis, stage of HIV infection and cognitive functioning. Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997 (Abstract)
19. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of HIV in the brain: correlations with HIV-associated dementia. Ann Neurol 1995;38:755-762
20. Miller EN, Selnes OA, McArthur JC, et al. Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 1990;40:197-203
21. Seines OA, Miller E, McArthur JC, et al. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology 1990;40:204-208
22. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-1083
23. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1 associated cognitive/motor disorder. Neurology 1996;47:1247-1253
24. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19
25. Giorgi JV, Cheng HL, Margolick JB, et al. Quality control in the flow cytometric measurement of lymphocyte-T subsets - the Multicenter AIDS Cohort Study experience. Clin Immunol Immunopathol 1990;55:173-186
26. McAithur JC, Nance-Sproson TE, Griffin DE, et al. The diagnostic utility of elevation in cerebrospinal fluid β2 microglobulin in HIV-1 dementia. Neurology 1992;42:1707-1712
27. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Invest 1977;37:385-390
28. Gerna G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994;32:2709-2717
29. Van Gemen B, van der Wiel P, van Beuningen R, et al. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl 1995;4:S177-S184
30. Vandamme A-M, Van Dooren S, Kok W, et al. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods 1995;52:121-132
31. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses 1995;11:353-361
32. Yen-Lieberman B, Brambilla D, Jackson B, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol 1996;34: 2695-2701
33. Schuurman R, Descamps D, Weverling GJ, et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:3016-3022
34. Boom R, Sol CJA, Salimans MMM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503
35. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579
36. Bell JE, Busuttil A, Ironside JW, et al. Human immunodeficiency virus and the brain: investigation of virus load and neuropathic changes in pre-AIDS subjects. J Infect Dis 1993;168: 818-824
37. Buffet R, Agut H, Chieze F, et al. Virological markers in the cerebrospinal fluid from HIV-1 infected individuals. AIDS 1991;5:1419-1424
38. Goswami KK, Miller RF, Harrison MJ, et al. Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. J Acquir Immune Defic Syndr 1991;5:797-803
39. Portegies P, Epstein LG, Hung ST, et al. Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status. Arch Neurol 1989;46:261-264
40. Royal W, Seines OA, Concha M, et al. Cerebrospinal fluid HIV-1 p24 antigen levels in HIV-1-related dementia. Ann Neurol 1994;36:32-39
41. Steuler H, Munzinger S, Wildemann B, Storch-Hagenlocher B. Quantitation of HIV-1 proviral DNA in cells from cerebrospinal fluid. J Acquir Immune Defic Syndr 1992;5:405-408
42. Conrad A, Schmid P, Syndulko K, et al. PCR detection and quantitation of serum and cell-free CSF RNA in HIV disease. Neurology 1995;45(suppl 4):A442 (Abstract)
43. Di Stefano M, Monno L, Fiore JR, Angarano G. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis. AIDS 1997;11:133-135 (Letter)
44. Harrison MJG, McArthur JC. Investigations. In: AIDS and Neurology. Edinburgh: Churchill Livingstone, 1995:219-240
45. Dewhurst S, Gelbard HA, Fine SM. Neuropathogenesis of AIDS. (Review). Mol Med Today 1996;2:16-23
46. Wesselingh SL, Power C, Glass J, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-582
47. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic nitric oxide synthase: Elevation in severe AIDS dementia and induction by HIV-1 coat protein, gp41. Science 1996;274: 1917-1921
48. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332: 934-940
49. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med 1996;2:625-629
50. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-431
51. Merigan TC, Schooley RT. Surrogate markers of HIV: strategies and issues for selection and use. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10(suppl 2):S1-S116
52. Ho DD. Viral counts and HIV infection. Science 1996;272: 1124-1125
53. Sacktor NC, Bacellar H, Hoover DR, et al. Psychomotor slowing in HIV infection predicts increased risk of dementia, AIDS, and death. J Neurovirol 1996;2:404-410
54. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol 1991;22: 700-710
55. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-570
56. Takahashi K, Wesselingh SL, Griffin DE, et al. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996;39: 705-711
57. Bagasra O, Lavi E, Bobroski L, et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals -identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996;10:573-585
58. Dickson DW, Lee SC. Microglia in HIV-related CNS neuropathology: an update. J Neuro-AIDS 1996;1:57-83
59. Johnson RT, Glass JD, McArthur JC, Chesebro BW. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol 1996;39:392-395
60. McArthur JC, Cohen BA, Farzedegan H, et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988;23:S34-S37
61. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-1497
62. Resnick L, diMarzo-Veronese F, Schupbach J et al. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med 1985;313:1498-1504
63. Marshall DW, Brey RL, Cahill WT, et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988;45:954-958
64. Nogales-Gaete J, Syndulko K, Tourtellotte WW. Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease. Ital J Neurol Sci 1992;13:667-683
65. Margolick JB, McArthur JC, Scott ER, et al. Flow cytometric quantitation of T cell phenotypes in cerebrospinal fluid and peripheral blood of homosexual men with and without antibodies to human immunodeficiency virus type I. J Neuroimmunol 1988;20:73-81
66. McArthur JC, Sipos E, Cornblath DR, et al. Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 1989;39:66-70
67. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373: 117-122
68. Sninsky JJ, Kwok S. The application of quantitative polymerase chain reaction to therapeutic monitoring. AIDS 1993;7(suppl 2):S29-S34